:: CLDF ::

Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease

Clin Gastroenterol Hepatol. 2021 Jun;19(6):1240-1247.e5. doi: 10.1016/j.cgh.2020.07.023.Epub 2020 Jul 16.

Donghee Kim¹, Soumya Murag², George Cholankeril³, Amanda Cheung³, Stephen A Harrison⁴, Zobair M Younossi⁵, Aijaz Ahmed³

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

EClinicalMedicine. 2021 Sep 5;40:101116. doi: 10.1016/j.eclinm.2021.101116. eCollection 2021 Oct.

Jenny Bischoff¹, Wenyi Gu², Carolynne Schwarze-Zander^1 3, Christoph Boesecke^1 3, Jan-Christian Wasmuth^1 3, Kathrin van Bremen¹, Leona Dold^1 3, Jürgen K Rockstroh^1 3, Jonel Trebicka²

Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare

Dig Dis Sci. 2021 Sep;66(9):3186-3191. doi: 10.1007/s10620-020-06588-6. Epub 2020 Sep 7.

Gabrielle Ritaccio^# 1, Gianna Stoleru^# 1, Ameer Abutaleb², Raymond K Cross², Kirti Shetty², Sasan Sakiani², Uni Wong³

Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study

Eur J Nutr. 2021 Jun;60(4):1761-1767. doi: 10.1007/s00394-020-02369-z.Epub 2020 Aug 27.

Yang Zhang^# 1, Zhipeng Liu^# 2, Tasnim Choudhury¹, Marilyn C Cornelis³, Wanqing Liu^4 5 6

Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies

Clin Gastroenterol Hepatol. 2021 Jul;19(7):1443-1450.e6. doi: 10.1016/j.cgh.2020.07.065.Epub 2020 Aug 5.

Nabihah Tayob¹, Douglas A Corley², Israel Christie³, Lucy Almers², Ahmed K Rahal⁴, Peter Richardson³, Donna L White³, Jessica Davila³, Fasiha Kanwal³, Hashem B El-Serag⁵

External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population

Dig Dis Sci. 2021 Jul;66(7):2387-2393. doi: 10.1007/s10620-020-06501-1. Epub 2020 Aug 5.

Maya Balakrishnan¹, Aradhna Seth^2 3, Nahir Cortes-Santiago⁴, Shilpa Jain⁴, Gagan K Sood⁵, Hashem B El-Serag³, Aaron P Thrift^6 7

Effects of sodium-glucose co-transporter 2 inhibitors on liver parameters and steatosis: A meta-analysis of randomized clinical trials

Diabetes Metab Res Rev. 2021 Sep;37(6):e3413. doi: 10.1002/dmrr.3413. Epub 2020 Oct 12.

Francisca Dos Santos Coelho^1 2, Marta Borges-Canha^1 2 3, Madalena von Hafe^1 2, João Sérgio Neves^1 2 3, Catarina Vale^1 2, Ana Rita Leite^1 2, Davide Carvalho^3 4, Adelino Leite-Moreira^1 2 5

Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study

Eur J Nutr. 2021 Jun;60(4):1769-1780. doi: 10.1007/s00394-020-02370-6. Epub 2020 Aug 28.

Cristina Galarregui¹, Irene Cantero¹, Bertha Araceli Marin-Alejandre¹, J Ignacio Monreal^2 3, Mariana Elorz^2 4, Alberto Benito-Boillos^2 4, José Ignacio Herrero^2 5 6, Víctor de la O^2 7, Miguel Ruiz-Canela^2 7 8, Helen Hermana M Hermsdorff⁹, Josefina Bressan⁹, Josep A Tur^8 10, J Alfredo Martínez^1 2 8, M Angeles Zulet^{# 11 12 13}, Itziar Abete^{# 14 15 16}

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease

J Magn Reson Imaging. 2021 Jun;53(6):1623-1631. doi: 10.1002/jmri.27292.Epub 2020 Aug 21.

Jelte J Schaapman¹, Maarten E Tushuizen², Minneke J Coenraad², Hildo J Lamb¹

10.

Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population

Clin Gastroenterol Hepatol. 2021 Jun;19(6):1258-1266.e1. doi: 10.1016/j.cgh.2020.08.012.Epub 2020 Aug 12.

Jun Wang¹, Anna H Wu¹, Frank Z Stanczyk², Jacqueline Porcel³, Mazen Noureddin⁴, Norah A Terrault⁵, Lynne R Wilkens⁶, Veronica Wendy Setiawan⁷

11.

Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018

Clin Gastroenterol Hepatol. 2021 Jul;19(7):1499-1501.e2. doi: 10.1016/j.cgh.2020.08.017.Epub 2020 Aug 12.

Donghee Kim¹, George Cholankeril², Rohit Loomba³, Aijaz Ahmed²

12.

Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD

Clin Gastroenterol Hepatol. 2021 Sep;19(9):1915-1924.e6. doi: 10.1016/j.cgh.2020.09.044.Epub 2020 Sep 30.

Tolga Gidener¹, Omar T Ahmed¹, Joseph J Larson², Kristin C Mara², Terry M Therneau², Sudhakar K Venkatesh³, Richard L Ehman³, Meng Yin³, Alina M Allen⁴

13.

Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD

Dig Liver Dis. 2021 Sep;53(9):1154-1158. doi: 10.1016/j.dld.2020.09.021. Epub 2020 Oct 13.

Antonella Mosca¹, Annalisa Crudele², Antonella Smeriglio³, Maria Rita Braghini², Nadia Panera², Donatella Comparcola⁴, Arianna Alterio⁴, Maria Rita Sartorelli⁴, Giulia Tozzi¹, Massimiliano Raponi⁵, Domenico Trombetta³, Anna Alisi⁶

14.

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Gut. 2021 Jul;70(7):1375-1382. doi: 10.1136/gutjnl-2020-322786. Epub 2020 Oct 9.

Tracey G Simon^1 2 3, Bjorn Roelstraete⁴, Hamed Khalili^1 2 3, Hannes Hagström⁵, Jonas F Ludvigsson^{6 7 8 9 10}

15.

Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD

Clin Gastroenterol Hepatol. 2021 Jun;19(6):1267-1274.e1. doi: 10.1016/j.cgh.2020.09.045.Epub 2020 Oct 1.

Monika A Sarkar¹, Ayako Suzuki², Manal F Abdelmalek², Katherine P Yates³, Laura A Wilson³, Nathan M Bass⁴, Ryan Gill⁵, Marcelle Cedars⁶, Norah Terrault⁷, NASH Clinical Research Network

16.

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans

Mol Metab. 2021 Aug;50:101122. doi: 10.1016/j.molmet.2020.101122.Epub 2020 Nov 19.

Kalliopi Pafili¹, Michael Roden²

17.

The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease

Clin Gastroenterol Hepatol. 2021 Oct;19(10):2199-2201. doi: 10.1016/j.cgh.2020.09.038.Epub 2020 Sep 30.

Hannah P Kim¹, Victor Navarro², Steven Zacks³, Joseph Odin⁴, David E Kleiner⁵, Paul H Hayashi⁶, Drug-Induced Liver Injury Network Investigators

18.

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

Dig Dis Sci. 2021 Sep;66(9):3192-3198. doi: 10.1007/s10620-020-06618-3. Epub 2020 Sep 27.

Vincent L Chen¹, Fadi Hawa², Jeffrey A Berinstein³, Chanakyaram A Reddy³, Ihab Kassab⁴, Kevin D Platt³, Chia-Yang Hsu³, Calen A Steiner³, Jeremy Louissaint³, Naresh T Gunaratnam⁵, Pratima Sharma³

19.

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis

Hepatology. 2021 Jun;73(6):2238-2250. doi: 10.1002/hep.31576. Epub 2021 Apr 19.

Luis Calzadilla-Bertot¹, Eduardo Vilar-Gomez^2 3, Vincent Wai-Sun Wong⁴, Manuel Romero-Gomez³, Rocio Aller-de la Fuente⁵, Grace Lai-Hung Wong⁴, Marlen Castellanos⁶, Mohammed Eslam⁷, Archita P Desai², Gary P Jeffrey^1 8, Jacob George⁷, Naga Chalasani², Leon A Adams^1 8

20.

Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard

Clin Infect Dis. 2021 Jun 15;72(12):2124-2131. doi: 10.1093/cid/ciaa429.

Veeral H Ajmera^1 2, Edward R Cachay³, Christian B Ramers⁴, Shirin Bassirian¹, Seema Singh¹, Richele Bettencourt¹, Lisa Richards¹, Gavin Hamilton⁵, Michael Middleton⁵, Katie Fowler⁵, Claude Sirlin⁵, Rohit Loomba^1 2 6

21.

Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease

Clin Gastroenterol Hepatol. 2021 Oct;19(10):2202-2204. doi: 10.1016/j.cgh.2020.09.039.Epub 2020 Sep 30.

Samarth Patel¹, Mohammad Bilal Siddiqui², Jose Hernandez Roman³, Emily Zhang⁴, Emily Lee⁴, Steve Shen⁴, Masoud Faridnia³, Robert J Mintini⁵, Sherry Boyett⁵, Michael O Idowu⁶, Arun J Sanyal¹, Velimir A Luketic¹, Mohammad Shadab Siddiqui¹